-
Mashup Score: 31Scientists report that new gene therapy slows down amyotrophic lateral sclerosis disease progression - 1 month(s) ago
There has been a breakthrough in the research on the disease amyotrophic lateral sclerosis (ALS). Scientists at Umeå University report that the disease progression in a patient with a particularly aggressive …
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
A symposium at the 2023 American Thoracic Society (ATS) International Conference featured research on predictors of chronic obstructive pulmonary disease (COPD) occurrence and disease progression.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 19Study identifies therapeutic target for Alzheimer's disease, revealing strategy for slowing disease progression - 2 year(s) ago
About 11% of the U.S. population 65 and older has been diagnosed with Alzheimer’s disease (AD), the most common form of dementia that results in memory loss and cognitive impairment, according to the Alzheimer’s Association.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 4Trastuzumab deruxtecan shows ‘terrific activity’ in second line for breast cancer subset - 2 year(s) ago
Source/Disclosures Published by: Disclosures: Cortés reports consultant/advisory roles with, honoraria from,…
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 6
Meningiomas, tumors of the membranes (meninges) surrounding the brain and spinal cord, are the most common tumors of the central nervous system. Although most meningiomas are low grade and cause few or no symptoms, a subset, called high-grade meningiomas, can cause serious neurologic and cognitive problems and have high mortality rates.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Losmapimod Improves Function and Slows Progression of Facioscapulohumeral Muscular Dystropy - Practical Neurology - 3 year(s) ago
Although the phase 2b ReDUX4 study (NCT04264442) of losmapimod (Fulcrum Therapeutics, Cambridge, MA) for treatment of facioscapulohumeral muscular dys
Source: Practical NeurologyCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 4
There are no approved drugs to treat nonalcoholic fatty liver disease but controlling blood sugar over time may help decrease the risk of liver scarring and disease progression.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real‐World Evidence Analysis - 4 year(s) ago
This article analyzes the use of palliative chemotherapy in metastatic breast cancer, in aggregate and by cancer subtype, to better understand the effectiveness of single‐agent versus combination che…
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Blood Test May Help Predict Disease Progression in Individuals with Multiple Sclerosis - Practical Neurology - 4 year(s) ago
A study published in Neurology shows that a blood test may help predict worsening of multiple sclerosis (MS) likely to occur within the next yea
Source: Practical NeurologyCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real‐World Evidence Analysis - 4 year(s) ago
This article analyzes the use of palliative chemotherapy in metastatic breast cancer, in aggregate and by cancer subtype, to better understand the effectiveness of single‐agent versus combination che…
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Scientists report that new gene therapy slows down amyotrophic lateral sclerosis #diseaseProgression https://t.co/wpZ4vMd3e2